MacroGenics Provides Update on Corporate Progress and 2nd Quarter 2018 Financial Results

Go back to MacroGenics Provides Update on Corporate Progress and 2nd Quarter 2018 Financial Results

Macrogenics (MGNX) Tops Q2 EPS by 19c

August 7, 2018 5:00 PM EDT

Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($1.03), $0.19 better than the analyst estimate of ($1.22). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $4.21 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

... More